Biopsy Devices Industry Growth Insights: Revenue Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the neurophotonics market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Biopsy Devices Market?
The biopsy devices market has observed substantial growth in recent years. It is anticipated to increase from $3.24 billion in 2025 to $3.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. The expansion seen in previous periods can be linked to several factors including rising cancer screening rates, an increase in diagnostic imaging centers, the expanded application of biopsy procedures for early detection, the presence of advanced imaging technologies, and improved diagnostic capacities in hospitals.
The biopsy devices market is projected to experience robust expansion over the coming years. This market is predicted to reach $4.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. The anticipated growth during this period stems from factors such as the greater acceptance of AI-assisted biopsy guidance, a surge in demand for outpatient diagnostic procedures, the broadening scope of precision oncology practices, an elevated emphasis on early disease detection, and increased capital flowing into advanced biopsy technologies. Key trends expected during the forecast timeframe encompass the wider integration of image-guided biopsy systems, a growing preference for minimally invasive biopsy techniques, an escalating need for precision sampling devices, the proliferation of automated biopsy guidance technologies, and a heightened commitment to diagnostic accuracy.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp
What Drivers Are Supporting Technological Adoption In The Biopsy Devices Market?
An increasing volume of surgical procedures is anticipated to propel the expansion of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders using both manual and instrumental methods. In these surgical contexts, biopsy devices are frequently employed to collect small tissue samples or cell clusters for subsequent laboratory analysis. For example, in July 2025, the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, reported a 42.5% increase in cosmetic procedure volumes over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Therefore, the growing number of surgeries is a key driver for the biopsy devices market’s growth moving forward.
What Segment Types Are Examined In The Biopsy Devices Market?
The biopsy devices market covered in this report is segmented –
1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies
3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications
4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User
Subsegments:
1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns
2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps
3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems
4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles
5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions
Which Trends Are Shaping Activity Within The Biopsy Devices Market?
Leading companies operating in the biopsy devices market are concentrating on developing advanced solutions, such as fine-needle biopsy precision technology, to enhance both diagnostic accuracy and sample quality. This fine-needle biopsy precision technology involves the engineering of needles with specialized tips and durable materials to improve tissue extraction while maintaining cellular architecture, thus supporting dependable pathology analysis. For instance, in October 2025, Olympus, a Japan-based medical-technology company, introduced its SecureFlex single-use fine-needle biopsy device, which features nitinol construction and a dual-beveled Raptor Tip. This tip assists in collecting larger, intact tissue specimens by minimizing tissue escape and improving puncture capabilities. The device’s construction includes a multi-layer sheath that allows for consistent access to complex anatomical structures like the pancreatic head and uncinate process without requiring frequent scope adjustments. SecureFlex supports fine-needle biopsy through EUS-FNB for gastrointestinal lesions, enabling physicians to obtain high-quality tissue for precise diagnosis and subsequent treatment planning. This device contributes to superior sample quality, increased procedural efficiency, and enhanced safety in endoscopic biopsy procedures.
Who Are The Top-Performing Companies In The Biopsy Devices Market In Recent Years?
Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Which Region Currently Holds The Largest Share Of The Biopsy Devices Market?
North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Biopsy Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp
Browse Through More Reports Similar to the Global Biopsy Devices Market 2026, By The Business Research Company
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Smart Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Liquid Biopsy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
